👩🏻🎓Data from a master’s thesis by one of our enthusiastic med. students:
🧠 The risk of overt HE is highest in patients with both large shunts (SPSS) and Minimal HE (MHE).
🧠 MHE alone has a higher risk that shunts alone.
Lactulose was not protective when SPSS were present.
Hey #Livertwitter
CHECK IT OUT 👉 @MontagneseSara, Michael Sørensen, and I wrote this short review on the social and psychological impact of #HE and how to mitigate that impact:
link.springer.com/article/10…
🤗 A-team!
It was a pleasure hosting @MMLauridsen in our lab! She is an absolute dynamo & gets things done, incl teaching Danish 🇩🇰, feeding licorice & having fun!
Some products (more coming!) ⤵️
sciencedirect.com/science/ar…
clinicaltrials.gov/study/NCT…
liverinstitute.medschool.vcu…
journals.lww.com/cld/fulltex…
Wrapping up a year-long research visit hosted by
@JasmohanBajaj
@ArunJSanyalVCU
and, not least, Dr. Sterling 🫶
#livertwitter keep an 👁️ on @VCU_Liver - they have great plans!
Looking forward to reuniting with @LiverEsbjerg @ATLAS_SDU and friends from @FLASH_OUH
Final day of #EASLCongress!
@dthabut and I started out strong by chairing a Meet the Experts on #HE.
We discussed HE prevention before TIPS, sleep, driving and more with dedicated people from across Europe.
@EASLnews #livertwitter @ISHENliver
You should have been there!
Great session on major killers of #QOL in #cirrhosis:
SEXUAL DYSFUNCTION
PAIN
STIGMA
FATIGUE AND FRAILTY
The good news is that simply acknowledging these issues can help the patient cope. But there is a lot more you can do!
1
12
624
Food for thought 🤔
- the right nutrition is medicine in #cirrhosis + HE
It may require resources to make and deliver tailored food but it could be worth it. I hope the RCT will tell us.
Cool feasibility study by @JasmohanBajaj @ebtapper & Anna Lok👇🏻
jcehepatology.com/article/S0…
6
559
Treat your decomp #cirrhosis patients for M/HE before ACLF:
- test and treat early on
- check up on compliance and effect regularly
- cross your fingers that they can withstand a future ACLF event because then rifaximin will have no effect 👇
In the 📕#RedJournal:
Antibiotics With or Without Rifaximin for Acute Hepatic Encephalopathy in Critically Ill Patients With Cirrhosis: A Double-Blind, Randomized Controlled (ARiE) Trial
Kulkarni, et al.
👉 bit.ly/4bcCicm
@AnandVKulkarni2 @MLongMD @JasmohanBajaj
MetteMunkLauridsen retweeted
🟪NEW Article in press❕
Proton pump inhibitor use and risk of hepatic encephalopathy: a multicenter study
🔓#OpenAccess at 👉jhep-reports.eu/article/S258…
#LiverTwitter
#HepaticEncephalopathy
MetteMunkLauridsen retweeted
Embarrassing to be Danish🙂↕️ @WHO_Europe report #Denmark again worst among 44 countries in alcohol use among 15 yr olds
Politicians keep age limit 16 yr, refuse to limit marketing, accept low prices - wake up‼️ Alcohol related harm is a real thing!
who.int/europe/publications/…
Surprised to see that in this solid, multi-center, and manually curated cohort, #PPI did not impact the #HE risk in #cirrhosis
Thank you, @c_labenz and team, for compiling these data.
Is PPI use associated with HE? Our multicenter study says no 🚫
✅1160 patients with PHES at baseline
🚫no association between PPI use and MHE or OHE development
🚫>70% without an indication for a PPI prescription❗️
👉read the study here: jhep-reports.eu/article/S258…
4
258
Are you busy with #hepatology clinical work?
Check out the clinical care points in this short and concise review on the cerebral effects of #cirrhosis and #portalhypertension from a group of @ISHENliver members.
Out now in Clinics in #LiverDisease. 👇
authors.elsevier.com/a/1i-BM…
MetteMunkLauridsen retweeted
Two great speakers talking about how muscle influences brain function in health and liver disease! Not to be missed! May 7th. Can’t wait. @CASLupdates @EASLedu @AASLDtweets
📢 Join us for the sixth ISHEN translational presentation series:
🗓️ When: May 7th 2024
✅ Invited speakers:
- Johannes Burtscher @JohBurtscher
- Aldo J. Montano-Loza @aldomontanoloza
⬇️ Registration ⬇️
umontreal.zoom.us/meeting/re…
New meta analysis in @AmJGastro
Across 101 studies MHE prevalence is
➡️ 40% worldwide
➡️ Highest in ALD - 46%
➡️ increases with CP score, age and lower education
2/3 of studies use PHES for diagnosis
How is MHE managed in your clinic?
journals.lww.com/ajg/fulltex…
Replying to @ATLAS_SDU
@ATLAS_SDU center extension kick-off!
Focus of our @GrundforskFond center:
📈Clinical and cellular nuances in #obesity and #MASLD disease progression
📣Organ cross-talk in obesity
🌕 Adipose tissue plasticity
🩸#MASH biomarkers
@susanslusser @ravnskjaer_lab @jespergrud
1
4
152
Team: @CharlotteWERN @FTibertLarsen @Daniel_H_dk @Grontved_Group @AnneloftSdu @FiskerSchmidt @ravnskjaer_lab @susmandrup @jespergrud @FiskerSchmidt @EllenGammelmark @AleksanderKrag
2
140
⭐️⭐️⭐️⭐️⭐️ Would warmly recommend to internationalize!
Thanks @JasmohanBajaj and @VCU_Liver for hosting me.
Danish hepatologist @MMLauridsen came to the institute for research, adventure and some serious downtime for writing. Her work here includes collaborating with @JasmohanBajaj as well as participating in the prestigious @VCU_GEHLI leadership program. bit.ly/4ao03gK
21
659
MASLD AND THE 🧠
We observed cognitive dysfunction in 40% of patients with BMI>35
New 🐁-study by @kristoffer_kj and colleagues suggest multi-level inflammation may the driver.
Is it reversible? 🤔
@ISHENliver @ISHENtranslatio
❕Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammation
🔓#OpenAccess at 👉 jhep-reports.eu/article/S258…
#LiverTwitter
MetteMunkLauridsen retweeted
🎉Last chance to sign up (for the reception part)
Reminder: We celebrate the kick-off of ATLAS 2.0 with a mini-symposium. Talks by center director @susmandrup and center members on the journey so far and what is to come!
Register for the event here: event.sdu.dk/atlaskickoff


































